ABSTRACT

Functional and ultrastructural abnormalities of respiratory cilia have been de­scribed in patients with a congenital respiratory disease known as primary ciliary dyskinesia (PCD) (1,2). PCD, previously described as immotile cilia syndrome, represents a heterogeneous group of genetic disorders affecting 1 in 16,000 indi-

* This work was previously published by the University of Chicago Press in American Journal of Human Genetics 65(6): 1508-1519, 1999. 119

viduals; the PCD phenotype is characterized by impaired mucociliary clearance resulting from a lack of ciliary movements believed to be responsible for chronic lung, sinus, and middle ear diseases. Approximately 50% of the patients with PCD display a situs inversus, thereby defining the Kartagener’s syndrome. Most male patients are infertile because of nonmotile spermatozoa in relation to func­tional and ultrastructural abnormalities of sperm flagella (3). Studies to date, how­ever, have failed to decipher the molecular basis of this disease. PCD is usually transmitted as an autosomal recessive trait. The various functional and ultrastruc­tural abnormalities of respiratory cilia documented in PCD patients suggest that a genetic heterogeneity underlies this condition (4).The main ciliary defect found in PCD is an absence of dynein arms affect­ing almost all cilia (3). Dyneins consist of a large family of proteins involved in many types of microtubule-dependent cell motility in both lower and higher eukaryotes. The axonemal dyneins are found in the dynein arms of the ciliary and flagellar axonemes; they are essential for ciliary and flagellar beating.Among the several immotile strains of Chlamydomonas reinhardtii, the mutants carrying a defect in IC78 gene, which encodes a dynein intermediate chain, have been the subject of detailed functional, ultrastructural, and molecular studies (5). Of particular interest, the flagellar ultrastructural phenotype of these mutants is similar to the axonemal ultrastructural abnormality observed in several PCD patients (i.e., absence of outer dynein arms); we have therefore isolated a human gene related to IC78, the DNAI1 gene (6), to test its involvement in PCD. CLINICAL AND ULTRASTRUCTURAL PHENOTYPES OF THE PCD PATIENTS

A 9-year-old Caucasian boy (patient II-1) bom to unrelated parents (family 1) presented in early childhood with chronic respiratory symptoms characterized by chronic sinusitis, serous otitis, and recurrent episodes of bronchitis associated with severe segmental atelectasis, having led to partial lobectomy. Chest radio­graph showed normal cardiac and visceral situs. Neither his parents nor other relatives have a history of respiratory disease. At the time of a bronchoscopy, samples of trachea mucosa were obtained and processed for ciliary studies, as described (7). No ciliary beating was observed, and transmission electron micros­copy showed the absence of outer dynein arms in all cilia, asserting the diagnosis of PCD (Fig. 1A). Five other unrelated consanguineous PCD families were also investigated (families 2 to 6). In two independent families (families 2 and 3), the ultrastructural phenotype was identical to that documented in patient II-1 from family 1; however, in one case (family 3), the PCD patients also displayed a situs inversus. In the three remaining families (families 4, 5, and 6), both outer and inner dynein arms were absent in the patients’ cilia; in one case (family 6), the disease phenotype was associated with a situs inversus. In all these individu-

als, DNA samples were isolated from peripheral blood samples, according to standard techniques. DNAI1 MUTATIONS LEAD TO A PCD PHENOTYPE

All the coding regions and intron-exon boundaries of the DNA sample from the patient II-1 from family 1 were amplified with DNAI1-specific primers and run on single-strand conformation polymorphism (SSCP) gels or sequenced directly. Two SSCP variants were identified in his genomic DNA; these variants were located in two PCR fragments spanning exon 5 (Fig. 2A) and 1 (Fig. 3A), respec­tively. To characterize these molecular variations, we cloned the corresponding PCR products. A 4-bp insertion, located at codon 95, was present in 10 of the 20 clones spanning exon 5 (Fig. 2B). A similar experimental approach led to the identification of a 1-bp insertion in the splice-donor site following exon 1 (Fig. 3B). The patient therefore carries two different DNAI1 mutations, thereby demon­strating compound heterozygosity in keeping with the absence of consanguinity documented in this family.The maternal 4-bp insertion results in a frameshift leading to premature stop codon 24 amino acids downstream. To determine the consequences of the paternally inherited splice-donor-site mutation on the processing of DNAI1 tran­scripts, total RNA obtained from nasal epithelial cells of patient II-1 was reverse-transcribed. The resulting products were used as templates in a PCR assay per­formed with DNAI1-specific primers (Fig. 3C). Two molecular species were gen­erated: one of expected size (290 bp), and a 422-bp fragment, which was observed only in the patient’s sample and not in the control. Sequencing of these PCR

products (290 bp and 422 bp) revealed that the larger fragment contained a 132-bp insertion corresponding to the 5' intronic sequence following exon 1, indicat­ing the use of a cryptic splice-donor site in this intron at position 133 (Fig. 3D). Indeed, sequence analysis of the intronic region spanning this site revealed the existence of a perfect splice-donor-site consensus sequence at position 133 of intron 1. If translated, this abnormal DNAI1 transcript would result in a premature stop codon at position 73. To further test whether these two mutations are respon­sible for the PCD phenotype, 50 unrelated control individuals were screened for these DNA11 variations. None of their 100 chromosomes contained such muta­tions. LOCUS HETEROGENEITY IN PCD

In the course of this study, we identified two intragenic nucleotide polymor­phisms: one is located at nucleotide 42 (G > C) of intron 11; the other one is a G-to-A transition at nucleotide 1003 resulting in the V3351 substitution. These two intragenic polymorphisms were used to test the involvement of DNAI1 in the PCD phenotype identified in the five remaining families (families 2-6) in which the patients were bom to consanguineous unions. The genotype at these two loci was characterized by genomic DNA sequencing. In family 2, the two affected children, who displayed an absence of outer dynein arms in all cilia, and the healthy older sister share the same DNAI1 genotype, thereby demonstrating an exclusion of linkage between the DNAI1 gene and the PCD phenotype. In family 5, the two affected children who displayed a PCD phenotype characterized by an absence of both outer and inner dynein arms, carried different DNAI1 geno­types at nucleotide 42 of intron 11. In the three remaining consanguineous fami­lies (families 3, 4, and 6), the patients were found to be heterozygous at one or at the two intragenic loci (data not shown). CONCLUSION

We postulated that the human DNAI1 gene, which is homologous to the Chlamy-domonas IC78 gene, was an excellent candidate sequence to investigate in pa­tients with a PCD phenotype characterized by an absence of outer dynein arms. Indeed, Chlamydomonas IC78 protein belongs to outer dynein arms (8), and a lack of outer dynein arms has clearly been documented in the axonemes of Chla­mydomonas strains in which the IC78 gene is either deleted or disrupted by a large insertion (5). Two different trans-allelic germline DNAI1 mutations leading to frameshifts were indeed identified in one patient presenting with a PCD pheno­type associated with an absence of outer dynein arms. The 4-bp insertion identi­fied on the maternal DNAI1 allele, which probably arose by slippage replication, is predicted to produce a frameshift introducing a premature stop codon located

24 amino acids downstream. The paternal mutation is a splice defect; if translated, the abnormal DNAI1 transcript, which retains the first 132 nucleotides of intron 1, would result in a premature TGA stop codon at position 73. Both the maternal mutation and the paternal mutation should, therefore, generate severally truncated polypeptides lacking 85% and 95%, respectively, of the DNAI1 protein. Taken together, these data highly suggest that such truncated proteins, even if synthe­sized, could not play their key role in the outer dynein arm assembly. We there­fore conclude that these mutations, which were absent from 100 control chromo­somes, underlie the ultrastructural phenotype observed in this PCD patient. The documented immotile cilia are also consistent with the absence of outer dynein arms; this may be responsible for mucociliary impairment, which led to the severe chronic respiratory symptoms observed in this patient.We have also identified two nucleotide polymorphisms in DNAI1 that al­lowed us to demonstrate an exclusion of linkage between the DNAI1 gene and the PCD phenotype in five other families. These linkage data, which provide the first clear-cut demonstration of a locus heterogeneity in this condition, also reveal a higher complexity level of heterogeneity than first expected, since patients with identical ultrastructural defects may have mutations in other still unidentified genes; it is tempting to speculate that these latter genes may encode functional partners of DNAI1 involved in dynein arm assembly. Given the documented clinical, ultrastructural and genetic heterogeneity in PCD, it is, therefore, not surprising that genetic analyses performed in different sets of families did not allow to establish a reproducible genetic linkage between the disease phenotype and a given chromosomal region (9-11). However, in theory this kind of ap­proach could be fruitful if applied to the study of separate families, each being considered individually (12). Nevertheless, such genetic linkage studies have been hampered by the small size of affected families in which male patients are usually infertile. This is the reason why, as shown in the present study, approaches based on the investigation of candidate genes represent powerful alternatives. These candidate genes include the dynein gene family. This study illustrates the use of one particular Chlamydomonas flagellar mutant as an excellent model for axonemal abnormalities observed in PCD; as several other light (13), intermedi­ate (14,15), and heavy chains (16-20) of dynein have been implicated in other Chlamydomonas flagellar mutants, we consider the corresponding genes as good candidates for other subsets of PCD and related developmental diseases. ACKNOWLEDGMENTS

The authors wish to thank M. C. Millepied and M. Couprie (Ecole Superieure d’lngenieurs en Electrotechnique et Electronique (ESIEE)) for their help in de­termining the ciliary ultrastructural phenotype. This work was supported by grants from the Chancellerie des Universites (legs Poix), the Assistance Publique/

Hopitaux de Paris (CRC96125), and the Universite Paris XII (BQR). GP is therecipient of a fellowship from the Ministere de V Education Nationale, de la Re­cherche et de la Technologie. REFERENCES

1. BA Afzelius. A human syndrome caused by immotile cilia. Science 193:317-319, 1976.2. CM Rossman, JB Forrest, RM Lee, MT Newhouse. The dyskinetic cilia syndrome. Ciliary motility in immotile cilia syndrome. Chest 78:580-582, 1980.3. BA Afzelius. The immotile-cilia syndrome: a microtubule-associated defect. CRC Crit Rev Biochem 19:63-87, 1985.4. J Chao, JA Turner, JM Sturgess. Genetic heterogeneity of dynein-deficiency in cilia from patients with respiratory disease. Am Rev Respir Dis 126:302-305, 1982.5. CG Wilkerson, SM King, A Koutoulis, GJ Pazour, GB Witman. The 78,000 M(r) intermediate chain of Chlam ydom onas outer arm dynein is a WD-repeat protein re­quired for arm assembly. J Cell Biol 129:169-178, 1995.6. G Pennarun, E Escudier, C Chapelin, AM Bridoux, V Cacheux, G Roger, A Clement, M Goossens, S Amselem, B Duriez. Loss-of-function mutations in a human gene related to Chlam ydom onas reinhardtii dynein IC78 result in primary ciliary dyskine­sia. Am J Hum Genet 65:1508-1519, 1999.7. E Escudier, D Escalier, MC Pinchon, M Boucherat, JF Bemaudin, J Fleury-Feith. Dissimilar expression of axonemal anomalies in respiratory cilia and sperm flagella in infertile men. Am Rev Respir Dis 142:674-679, 1990.8. SM King, CG Wilkerson, GB Witman. The Mr 78,000 intermediate chain of Chla­mydomonas outer arm dynein interacts with alpha-tubulin in situ. J Biol Chem 266: 8401-8407, 1991.9. C Chapelin, S Amselem, M Jean-Pierre, B Duriez, A Coste, E Lesprit, J Janaud, et al. Genetic analysis of primary ciliary dyskinesia in six multiplex families. Am J Respir Crit Care Dis 155:A504, 1997.10. M Witt, Y Wang, S Wang, C Sun, J Pawlik, E Rutkiewicz, J Zebrak, SR Diehl. Exclusion of chromosome 7 for Kartagener syndrome but suggestion of linkage in families with other forms of primary ciliary dyskinesia. Am J Hum Genet 64:313-318, 1999.11. JL Blouin, M Meeks, U Radhakrishna, A Sainsbury, C Gehring, GD Sail, L Barto-loni, V Dombi, A O’Rawe, A Walne, E Chung, BA Afzelius, M Armengot, M Joris-sen, DV Schidlow, L van Maldergem, H Walt, RM Gardiner, D Probst, PA Gueme, CD Delozier-Blanchet, SE Antonarakis. Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity. Eur J Hum Genet 8:109-118, 2000.12. M Meeks, A Walne, S Spiden, H Simpson, H Mussaffi-Georgy, HD Hamam, EL Fehaid, M Cheehab, M Al-Dabbagh, S Polak-Charcon, H Blau, A O’Rawe, HM Mitchison, RM Gardiner, E Chung. A locus for primary ciliary dyskinesia maps to chromosome 19q. J Med Genet 37:241-244, 2000.13. M LeDizet, G Pipemo. ida4-l, ida4-2, and ida4-3 are intron splicing mutations af­

fecting the locus encoding p28, a light chain of Chlam ydom onas axonemal inner dynein arms. Mol Biol Cell 6:713-723, 1995.14. DR Mitchell, Y Kang. Identification of oda6 as a C hlam ydom onas dynein mutant by rescue with the wild-type gene. J Cell Biol 113:835-842, 1991.15. CA Perrone, P Yang, E O’Toole, WS Sale, ME Porter. The C hlam ydom onas IDA7 locus encodes a 140-kDa dynein intermediate chain required to assemble the II inner arm complex. Mol Biol Cell 9:3351-3365, 1998.16. H Sakakibara, DR Mitchell, R Kamiya. A C hlam ydom onas outer arm dynein mutant missing the alpha heavy chain. J Cell Biol 113:615-622, 1991.17. H Sakakibara, S Takada, SM King, GB Witman, R Kamiya. A Chlam ydom onas outer arm dynein mutant with a truncated beta heavy chain. J Cell Biol 122:653-661, 1993.18. ME Porter, JA Knott, LC Gardner, DR Mitchell, SK Dutcher. Mutations in the SUP-PF-1 locus of Chlam ydom onas reinhardtii identify a regulatory domain in the beta-dynein heavy chain. J Cell Biol 126:1495-1507, 1994.19. G Rupp, E O’Toole, LC Gardner, BF Mitchell, ME Porter. The sup-pf-2 mutations of C hlam ydom onas alter the activity of the outer dynein arms by modification of the gamma-dynein heavy chain. J Cell Biol 135:1853-1865, 1996.20. SH Myster, JA Knott, E O’Toole, ME Porter. The Chlam ydom onas Dhcl gene en­codes a dynein heavy chain subunit required for assembly of the II inner arm com­plex. Mol Biol Cell 8:607-620, 1997.